These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8464648)

  • 21. [Therapeutic effects of cefprozil in the treatment of various infectious diseases in children].
    Wakiguchi H; Ohishi N; Kido S; Takechi T; Takeda K; Yoshimura K; Nomura I; Fujieda M; Araki K; Kurashige T
    Jpn J Antibiot; 1992 Dec; 45(12):1676-83. PubMed ID: 1289587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Takajo N; Okabayashi S
    Jpn J Antibiot; 1992 Dec; 45(12):1700-35. PubMed ID: 1289589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefdinir: an expanded-spectrum oral cephalosporin.
    Guay DR
    Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics].
    Woo M; Higashino H; Kohdera U; Nakamura M; Kawasaki H; Kino M; Kobayashi Y
    Jpn J Antibiot; 1992 Dec; 45(12):1635-41. PubMed ID: 1289581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB; Bryson HM
    Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cephalosporin antibiotics in pediatric practice.
    Ross S; Rodriguez W; Khan W
    South Med J; 1977 Jul; 70(7):855-61. PubMed ID: 877649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
    McCarty JM
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B; Perry CM
    Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media.
    Blumer JL; Forti WP; Summerhouse TL
    Clin Ther; 1996; 18(5):811-20. PubMed ID: 8930425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redefining the management of pediatric tonsillopharyngitis with cefprozil.
    Jerath N; Shetty G
    Indian J Pediatr; 2007 Dec; 74(12):1105-8. PubMed ID: 18174646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summary: role of a new oral cephalosporin, cefdinir, for therapy of infections of infants and children.
    Klein JO; McCracken GH
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S181-3. PubMed ID: 11144402
    [No Abstract]   [Full Text] [Related]  

  • 32. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology and pharmacokinetics of cefprozil.
    Barriere SL
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S184-8; discussion S195-6. PubMed ID: 1617036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftibuten: a new expanded-spectrum oral cephalosporin.
    Guay DR
    Ann Pharmacother; 1997 Sep; 31(9):1022-33. PubMed ID: 9296244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Overall clinical evaluation of cefprozil against infections in pediatric fields. Pediatric Study Group for Cefprozil].
    Fujii R; Meguro H; Tajima T; Shiraishi H; Abe T; Nakazawa S; Sato H; Niinou K; Matsumoto K; Sunakawa K
    Jpn J Antibiot; 1992 Nov; 45(11):1592-608. PubMed ID: 1494240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety profile of cefprozil.
    Wilber RB; Doyle CA; Durham SJ; Conetta BJ; DeGraw SS; Leigh A
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S264-71; discussion S272. PubMed ID: 1617047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of bacterial infections of the upper respiratory tract in children: pharyngitis and otitis media.
    Adam D
    Manag Care Interface; 2000 Apr; 13(4):83-8. PubMed ID: 11066289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin.
    Klein JO
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary clinico-therapeutic trials of new cephalosporin: cefotaxime].
    Frongillo RF; Galuppo L; Dominici C
    Clin Ter; 1981 Jul; 98(1):25-35. PubMed ID: 6265143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of cefprozil in children].
    Mochizuki Y; Kanazashi S; Hata D; Ohkubo H; Itoh S; Mayumi M; Mikawa H
    Jpn J Antibiot; 1992 Dec; 45(12):1622-34. PubMed ID: 1289580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.